OR4T1P

Across TCGA pan-cancer cohorts, OR4T1P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated OR4T1P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher OR4T1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR4T1P expression acts as an unfavorable survival marker.

BLCA, SKCM, and BRCA are the cancer types where OR4T1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.122	0.693	<.001	90	view →
SKCM	OS	Tertile	All	0.175	0.787	<.001	36	view →
BRCA	OS	Tertile	III,IV	0.287	0.833	.002	36	view →
CHOL	OS	Tertile	All	0.154	0.793	.004	27	view →
GBM	DFS	Tertile	All	0.231	0.261	.004	21	view →
LGG	OS	Tertile	All	0.170	0.522	.028	12	view →
UCEC	DFS	Tertile	All	0.720	0.900	.015	12	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

OR4T1P–BLCA (OS)

Open the BLCA breakdown →